News
-
Enhancing Hiring at Healthcare Practices with Technology
The last few years, both during and after the pandemic, have been turbulent times for healthcare providers and patients alike. For now, although it appears that healthcare staffing shortages will continue, providers are not without practical strategies for attracting and retaining talent.
-
How Nemours Children’s Is Working to Solve the ‘Horrendous’ Youth Mental Health Crisis
If you could only do one thing to improve the health of children in the U.S., it would have to be in the behavioral health sphere, Nemours Children’s Health CEO Lawrence Moss declared at HLTH. The state of youth mental health has reached a crisis point in the U.S., and Moss’ health system is working hard to address this. Some of its efforts include embedding behavioral health into primary care and deploying behavioral health workers in schools.
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
4 Areas Within Digital Health That Will See Consolidation Next Year
At the HLTH conference last week, MedCity News’ editorial team interviewed 11 health leaders from a variety of organizations to get a sense of which areas within healthcare will see consolidation over the next 12 months.
-
Artificial Intelligence, Consumer / Employer, Health Tech, Hospitals, Patient Engagement, Startups
7 Hot Takes I Heard at HLTH
At HLTH 2023, I had dozens of conversations with providers, digital health investors, startup CEOs and other players in the healthcare industry. When I got home, I compiled seven refreshingly honest takes I heard from them while at the conference.
-
Pfizer Expands in Immunology With FDA Approval of New Ulcerative Colitis Drug
Pfizer’s new FDA-approved ulcerative colitis drug Velsipity comes from its $6.7 billion Arena Pharmaceuticals acquisition. The small molecule will compete against blockbuster Bristol Myers Squibb drug Zeposia, which addresses the same target.
-
Patient-Centric Digital Transformation: Rethinking Remote Monitoring for Comprehensive Care
A recent webinar sponsored by AVIA Health and Seamless MD examined how health systems use remote patient monitoring beyond the usual chronic condition applications, including surgical prep and recovery, women’s health, and more.
-
Health Tech for Aging Population Punctuates HLTH 2023
Health tech to support care for seniors and track the progression of conditions such as Parkinson’s disease and heart failure were on display at HLTH 2023. The National Institute on Aging also added a startup boot camp leading up to HLTH.
-
EU Orders Grail Sale; Illumina Continues Appeals But Plans for Multiple Outcomes
European Union regulators ordered Illumina to divest Grail. Illumina is appealing antitrust findings in Europe and the U.S., but the DNA sequencing giant revealed that divesting all or part of Grail is an option even if it wins both legal challenges.
-
4 Ways Investors Think the Health Tech World Will Change in 2024
At HLTH, Bessemer investors Sofia Guerra and Steve Kraus detailed four predictions about where they think the digital health world is headed in 2024. One of these was that “services-as-software” will emerge as a new category of healthcare AI. Another was that some healthcare technology vendors will have to rethink their distribution models and rely on indirect monetization strategies.
-
Navigating Healthcare’s Data Revolution: Priorities, Opportunities, and Challenges for Health Systems
Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here’s what we found.
-
Consumer / Employer, Employee Benefits
Walmart: Included Health Has Proved Its Value to Our Virtual Primary Care Program
Walmart’s relationship with Included Health dates back to 2016 when its previous incarnation – Doctor on Demand – began providing virtual urgent care services to Walmart employees in three states. Nearly eight years later, the San Francisco company continues to be the only partner charged with delivering virtual primary care to almost 1 million people in 49 states.
-
Consumer / Employer, Health Tech
Noom Offers Clinical Obesity Management Platform to Employers
Noom is now offering Noom Med to employers. The program is intended for patients who need more clinical support in their weight loss journey. It offers access to a clinician and medications, including GLP-1s.
-
BioNTech Turns to China Again for Cancer Drugs, Paying $70M to Partner on an ADC
BioNTech gains rights to a MediLink Therapeutics antibody drug conjugate that targets tumors expressing the HER3 protein. The deal comes six months after the German company entered the ADC field by acquiring rights to two therapeutic candidates from DualityBio.
-
3 Questions This Healthcare Investor Finds Herself Asking Startups All The Time
At HLTH, General Catalyst Principal Candace Richardson discussed some of the questions she frequently asks startups during investment meetings. Some of these include “Do you stratify your outcomes data by different populations to ensure your model works well for everyone?” and “Is serving Medicaid populations on your roadmap?”
-
Health Tech, Hospitals, Physicians
Why the AMA President Thinks Scope of Practice Expansions Are a ‘Terrible Idea’
To address the growing physician shortage, some people argue that the scope of practice should be expanded for skilled healthcare professionals like nurse practitioners and pharmacists. American Medical Association President Dr. Jesse Ehrenfeld said this is a “terrible idea.” He argued that throwing other professionals into physicians’ roles will have poor ramifications of patient safety. In his view, the industry should focus on uplifting strong interprofessional care teams.
-
Novo Nordisk’s Star Diabetes & Obesity Drug Shows Promise in Kidney Disease
A study testing Novo Nordisk’s semaglutide in chronic kidney disease is ending early after an interim analysis met efficacy goals. Detailed results are not yet available, but they could support expanding use of the GLP-1 agonist, which is far and away Novo Nordisk’s top-selling product.
-
Main Street Health Rakes In $315M to Scale Value-Based Care in Rural America
Main Street Health announced the close of a $315 funding round at HLTH — some of the investors included UnitedHealthcare, Humana, Elevance, Centene and CVS. The startup, which scales value-based care in rural areas for both Medicare Advantage and original Medicare patients, also announced that it is expanding to 26 states.
-
Pharma, Artificial Intelligence, BioPharma
Sanofi Adds Biologics to Its AI Ambitions, Striking Up R&D Alliance With BioMap
Formed by Baidu founder and CEO Robin Li, BioMap uses artificial intelligence technology to glean insight into proteins to guide biologic drug discovery. The startup is the latest company to join a growing list of Sanofi partners as the pharmaceutical giant continues investing in AI-enabled drug discovery.
-
Highmark Health, Spring Health Team Up for Mental Health Solution
Spring Health and Highmark Health are collaborating to launch Mental Well-Being, a solution that offers therapy, medication and other services for some Highmark members.
Promoted
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
